Mariusz Skwarczynski

Mariusz Skwarczynski has over 180 publications, including peer-reviewed journals, book chapters (Wiley, Springer Nature, Nova Science, Elsevier), and two edited book (Elsevier, Springer Nature) – as of 2023. Among these publications, 16 are in journals with an impact factor of 10-30. He was ranked 3rd in the world in the Subunit Vaccines field (2012-2022) by Expertscape's PubMed-based scheme and placed among the top 0.1% (0.022% of 18,308 published authors) of scholars writing about Subunit Vaccines over the past 10 years: https://expertscape.com/ex/vaccines%2C+subunit. He is an inventor on three patents that attracted interest from the industry including Meat & Livestock Australia Ltd, Vet-Agro Sp. z o.o., Paragen Bio, and Brandon Capital. He co-developed an epimerization-free method for the synthesis of novel building blocks (isodipeptides) for solid-phase peptide synthesis; these units have been commercialised by Merck-Novabiochem. Recently, he has been actively engaged in several projects aimed at the commercialisation of veterinary vaccines (mostly targeting domestic and wild animals’ fertility control) in Australia and Italy.

He is very active in a collaborative initiative between universities, on projects to develop vaccines against Group A Streptococcus, tuberculosis, hookworm, malaria, porcine circovirus, babesia and cancer, as well as other drug delivery systems. He is an Associate Editor in Frontiers in Pharmacology, (2016 – current) and Regional Editor of Australia in Vaccines (2018 – current). In addition to grants from the ARC and NHMRC, he is also the recipient of industry-specific grants (Economic Accelerator Launch Programme 2023 and Meat & Livestock Australia Limited grant 2021). He regularly communicates with the public (locally and internationally) on issues related to vaccine development and safety. His recent publication on the oral hookworm vaccine has attracted wide media interest from all over the world (Australia, India, China, Kenya, New Zealand, Hungary, Pakistan, etc.). He is often invited to present at international conferences, and recently he organised and chaired Micro and Nanoparticles in Drug and Vaccine Delivery Symposium, Brisbane, 2021.

He has served as a primary supervisor of four PhD students (two ongoings, two theses awarded) and co-supervisor of 23 PhD students in the medicinal chemistry, biotechnology, and vaccine development fields. All his former students have successfully found jobs, many of which are in the fields of biology or chemistry, across industry and academia, in Australia and abroad. Some notable examples of current employers of his past students include Harvard T.H. Chan School of Public Health, National University of Malaysia, The Translational Research Institute, Griffith University, Miltenyi Biotec Australia, James Cook University, Procter & Gamble, Woolcock Institute of Medical Research, WuXi Biologics, and Endologix California.